Khayat Rami, Jarjoura David, Porter Kyle, Sow Angela, Wannemacher Jacob, Dohar Robert, Pleister Adam, Abraham William T
Sleep Heart Program, The Ohio State University, Columbus, OH, USA
Center for Biostatistics, The Ohio State University, Columbus, OH, USA.
Eur Heart J. 2015 Jun 14;36(23):1463-9. doi: 10.1093/eurheartj/ehu522. Epub 2015 Jan 29.
Hospitalizations for heart failure are associated with a high post-discharge risk for mortality. Identification of modifiable predictors of post-discharge mortality during hospitalization may improve outcome. Sleep disordered breathing (SDB) is the most common co-morbidity in heart failure patients.
DESIGN, SETTING, AND PARTICIPANTS: Prospective cohort study of patients hospitalized with acute heart failure (AHF) in a single academic heart hospital. Between January 2007 and December 2010, all patients hospitalized with AHF who have left ventricular ejection fraction (LVEF) ≤ 45% and were not already diagnosed with SDB were the target population.
Patients underwent in-hospital attended polygraphy testing for SDB and were followed for a median of 3 years post-discharge. Mortality was recorded using national and state vital statistics databases.
During the study period, 1117 hospitalized AHF patients underwent successful sleep testing. Three hundred and forty-four patients (31%) had central sleep apnoea (CSA), 525(47%) patients had obstructive sleep apnoea (OSA), and 248 had no or minimal SDB (nmSDB). Of those, 1096 patients survived to discharge and were included in the mortality analysis. Central sleep apnoea was independently associated with mortality. The multivariable hazard ratio (HR) for time to death for CSA vs. nmSDB was 1.61 (95% CI: 1.1, 2.4, P = 0.02). Obstructive sleep apnoea was also independently associated with mortality with a multivariable HR vs. nmSDB of 1.53 (CI: 1.1, 2.2, P = 0.02). The Cox proportional hazards model adjusted for the following covariates: LVEF, age, BMI, sex, race, creatinine, diabetes, type of cardiomyopathy, coronary artery disease, chronic kidney disease, discharge systolic blood pressure <110, hypertension, discharge medications, initial length of stay, admission sodium, haemoglobin, and BUN.
This is the largest study to date to evaluate the effect of SDB on post-discharge mortality in patients with AHF. Newly diagnosed CSA and OSA during AHF hospitalization are independently associated with post-discharge mortality.
心力衰竭住院患者出院后死亡风险较高。识别住院期间出院后死亡的可改变预测因素可能改善预后。睡眠呼吸紊乱(SDB)是心力衰竭患者最常见的合并症。
设计、设置和参与者:在一家学术性心脏病医院对急性心力衰竭(AHF)住院患者进行的前瞻性队列研究。2007年1月至2010年12月期间,所有因AHF住院且左心室射血分数(LVEF)≤45%且尚未被诊断为SDB的患者为目标人群。
患者在住院期间接受了SDB的睡眠监测仪测试,并在出院后进行了为期3年的随访。使用国家和州生命统计数据库记录死亡率。
在研究期间,1117例住院的AHF患者成功进行了睡眠测试。344例患者(31%)有中枢性睡眠呼吸暂停(CSA),525例患者(47%)有阻塞性睡眠呼吸暂停(OSA),248例无或仅有轻微SDB(nmSDB)。其中,1096例患者存活至出院并纳入死亡率分析。中枢性睡眠呼吸暂停与死亡率独立相关。CSA与nmSDB相比,死亡时间的多变量风险比(HR)为1.61(95%CI:1.1,2.4,P = 0.02)。阻塞性睡眠呼吸暂停也与死亡率独立相关,与nmSDB相比,多变量HR为1.53(CI:1.1,2.2,P = 0.02)。Cox比例风险模型对以下协变量进行了调整:LVEF、年龄、BMI、性别、种族、肌酐、糖尿病、心肌病类型、冠状动脉疾病、慢性肾病、出院时收缩压<110、高血压、出院用药、初始住院时间、入院时钠、血红蛋白和尿素氮。
这是迄今为止评估SDB对AHF患者出院后死亡率影响的最大规模研究。AHF住院期间新诊断的CSA和OSA与出院后死亡率独立相关。